Latest Breaking News On - நந்தினி பிரமல் - Page 1 : comparemela.com

Piramal Pharma Agrees to Acquire Hemmo Pharmaceuticals Source: Piramal Pharma April 5, 2021 CDMO Piramal Pharma Solutions (PPS), based in Mumbai, India, agreed to acquire a 100% stake in Hemmo Pharmaceuticals in a deal that will add peptide API development and manufacturing capabilities to PPS’ operations. Hemmo, which is one of the few pure-play synthetic peptide API manufacturers in the global marketplace, according to PPS, is one of India’s largest manufacturers of synthetic peptides with a history of more than thirty-eight years in supplying peptide products and custom peptide synthesis. Hemmo reportedly has R&D capabilities and a world-class GMP manufacturing facility that has been inspected and deemed compliant by the U.S., EU, and Asian regulatory agencies. The company has strong expertise in both solution phase and solid phase synthesis of peptides, notes Nandini Piramal, chairperson, PPS.

Nandini piramalCdmo piramal pharma solutionsHemmo pharmaceuticalsPharma solutionsநந்தினி பிரமல்கதிமோ பிரமல் பார்மா தீர்வுகள்பார்மா தீர்வுகள்